Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,523 active trials9 approved drugs210 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06043232 | MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas | unknown | — | 360 | Huashan HospitalOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT06041347 | Learning Curve for the Visualization of Sacral Plexus on TVS(PlexUS) | unknown | — | 480 | Semmelweis UniversityOTHER | 1 | Sep 18, 2023 | clinicaltrials |
| NCT06040580 | Can we Use Resting-state fMRI and CSD Fiber Tractography for Presurgical Mapping? | unknown | — | 150 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Sep 15, 2023 | clinicaltrials |
| NCT06036732 | A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score | unknown | — | 223 | Istanbul University - CerrahpasaOTHER | 1 | Sep 14, 2023 | clinicaltrials |
| NCT05896007 | Zanubrutinib Combined With Rituximab and Chemotherapy for Newly-Diagnosed PCNSLBCL Patients Intolerant to HSCT | unknown | Phase 2 | 29 | Ruijin HospitalOTHER | 1 | Sep 5, 2023 | clinicaltrials |
| NCT05926427 | Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement | unknown | Phase 2 | 25 | Ruijin HospitalOTHER | 1 | Sep 5, 2023 | clinicaltrials |
| NCT04722237 | Acceptance and Commitment Therapy for Neuro-Oncology Wellbeing(ACT NOW) | unknown | N/A | 72 | Nottingham University Hospitals NHS TrustOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT05235737 | The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab(PIRG) | unknown | Phase 4 | 36 | Medical University of SilesiaOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT06018870 | MRI Contrast Clearance Analysis for Glioma Grading and Genotyping | unknown | — | 100 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Aug 31, 2023 | clinicaltrials |
| NCT05964153 | Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients | unknown | N/A | 10 | Corporacion Parc TauliOTHER | 1 | Aug 30, 2023 | clinicaltrials |
| NCT06015061 | Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients | unknown | — | 20 | Peking Union Medical College HospitalOTHER | 1 | Aug 29, 2023 | clinicaltrials |
| NCT06014398 | Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours | unknown | N/A | 50 | Royal College of Surgeons, IrelandOTHER | 1 | Aug 28, 2023 | clinicaltrials |
| NCT05802693 | A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma | unknown | Early Phase 1 | 22 | Beijing Tsinghua Chang Gung HospitalOTHER | 0 | Aug 25, 2023 | clinicaltrials |
| NCT05998486 | Detecting the Rest Tremor Associated With Parkinson's Disease Using Analysis of the Muscle Contractions Rhythmicity(TREMORHYTHM) | unknown | — | 80 | Henri Mondor University HospitalOTHER | 1 | Aug 21, 2023 | clinicaltrials |
| NCT01046123 | Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases | unknown | N/A | 60 | British Columbia Cancer AgencyOTHER | 1 | Aug 14, 2023 | clinicaltrials |
| NCT05984108 | Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System(MelaMen) | unknown | — | 50 | Central Hospital, Nancy, FranceOTHER | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05981170 | Rurality Adapted Physical Activity Sport Health(RAPASS) | unknown | — | 10 | Institut Cancerologie de l'OuestOTHER | 1 | Aug 8, 2023 | clinicaltrials |
| NCT04532229 | Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children | unknown | Phase 3 | 48 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05158712 | Genetic Factors and Pheochromocytomas in Neoplasia Type 2(NEM2A-Pheo) | unknown | — | 14 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05961111 | A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | unknown | Early Phase 1 | 20 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jul 27, 2023 | clinicaltrials |
| NCT02558244 | Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study | unknown | — | 100 | Assiut UniversityOTHER | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05958472 | Navigating the Clinical Research Process for Glioma | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05958485 | A Close Examination of Patient Experiences in Glioblastoma Multiforme Clinical Research | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jul 24, 2023 | clinicaltrials |
| NCT05950490 | Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma | unknown | — | 100 | Peking Union Medical College HospitalOTHER | 1 | Jul 18, 2023 | clinicaltrials |
| NCT05755295 | Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma(EQUI-HIPPO) | unknown | N/A | 15 | University Hospital, ToulouseOTHER | 1 | Jul 13, 2023 | clinicaltrials |
| NCT05635435 | Immune and Inflammatory Indices in Peripheral Blood Predict Prognosis of Glioma and Correlate With Grades and Subtypes | unknown | — | 1,282 | Sun Yat-sen UniversityOTHER | 1 | Jul 12, 2023 | clinicaltrials |
| NCT05549414 | Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System(PPTS) | unknown | N/A | 100 | P-CureINDUSTRY | 1 | Jul 10, 2023 | clinicaltrials |
| NCT04967690 | A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM(TARGLIO) | unknown | Phase 1 | 27 | Double Bond Pharmaceutical ABINDUSTRY | 0 | Jul 6, 2023 | clinicaltrials |
| NCT05929456 | Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)(MIRROR) | unknown | Phase 1 | 21 | University Medical Center GroningenOTHER | 1 | Jul 3, 2023 | clinicaltrials |
| NCT04671459 | TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine(TaRRGET) | unknown | Phase 2 | 40 | Prof. Franciszek Lukaszczyk Memorial Oncology CenterOTHER | 1 | Jun 28, 2023 | clinicaltrials |
| NCT05918432 | Determining Patterns In Study Experiences of Neuroblastoma Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 1 | Jun 26, 2023 | clinicaltrials |
| NCT05732896 | Comparison of Opioid Consumption During TCI Guided by NOL Index or Standard Care Undergoing Intracranial Tumor Surgery(NOLopioid) | unknown | N/A | 50 | Turkish Society of Anesthesiology and ReanimationOTHER | 1 | Jun 22, 2023 | clinicaltrials |
| NCT05901844 | Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During Surgery | unknown | N/A | 256 | Beijing Tiantan HospitalOTHER | 0 | Jun 13, 2023 | clinicaltrials |
| NCT05191784 | GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients | unknown | Phase 2 | 20 | Genexine, Inc.INDUSTRY | 1 | Jun 12, 2023 | clinicaltrials |
| NCT05728125 | Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Jun 12, 2023 | clinicaltrials |
| NCT04223999 | Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery)(OptimalTTF-2) | unknown | Phase 2 | 70 | Anders Rosendal KorshøjOTHER | 1 | Jun 6, 2023 | clinicaltrials |
| NCT05885399 | The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment | unknown | Phase 2 | 5 | Peking Union Medical College HospitalOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT04553341 | Induction of Cortical Plasticity | unknown | N/A | 40 | Technical University of MunichOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05885386 | A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jun 1, 2023 | clinicaltrials |
| NCT05883085 | A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL | unknown | Phase 2 | 10 | Peking Union Medical College HospitalOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT03411408 | Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma.(HBO-RT) | unknown | N/A | 24 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT05764460 | Social Cognition and Language in Patients With Gliomas | unknown | — | 105 | University Medical Center GroningenOTHER | 0 | May 17, 2023 | clinicaltrials |
| NCT05358340 | Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions | unknown | N/A | 100 | University Health Network, TorontoOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05816746 | Decitabine and Anti-PD-1 in R/R DLBCL | unknown | Phase 2 | 20 | Chinese PLA General HospitalOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT05850377 | 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas | unknown | — | 90 | Sociedad de Lucha Contra el Cáncer del EcuadorOTHER | 1 | May 9, 2023 | clinicaltrials |
| NCT02137759 | MRSI to Predict Response to RT/TMZ ± Belinostat in GBM | unknown | Phase 2 | 29 | Emory UniversityOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05844605 | Prehabilitation, Rehabilitation and Comprehensive Approach to the Sequelae of Brain Tumors(PREHABILITA) | unknown | Phase 1 | 20 | Institut GuttmannOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT05781919 | Use of Virtual Reality for Surgical Planning in Neuroblastoma(VRNB) | unknown | N/A | 130 | Hospital Sant Joan de DeuOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT05803057 | Accelerating Motor Recovering in Patients With SMA Syndrome After Glioma Surgery by Using nrTMS | unknown | N/A | 64 | Beijing Neurosurgical InstituteOTHER | 1 | May 3, 2023 | clinicaltrials |
| NCT02608762 | Neurobehavioral Outcomes and Quality of Life in Pediatric Patients With Brain or Head/Neck Tumors Receiving Proton or Photon Radiotherapy | unknown | — | 72 | Chang Gung Memorial HospitalOTHER | 1 | May 1, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Sep 21, 2023source: clinicaltrials